|
|
|
|
|
Delaware
|
|
001-38536
|
|
20-3352427
|
|
|
(State or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
|
|
|
180 N. LaSalle Street, Suite 1600
Chicago, Illinois 60601
(Address of principal executive offices, including zip code)
|
|
||||
|
|
|
|
|
|
|
|
|
|
(844) 445-5704
|
|
|
|
(Registrant's telephone number, including area code)
|
||||||
|
|
|
|
|
|
|
|
|
|
Not Applicable
|
|
|
|
(Former name or former address, if changed since last report)
|
|
|
|
|
Class I Director Nominee
|
|
For
|
|
Withhold
|
|
Broker Non-Votes
|
BJ Bormann
|
|
8,619,383
|
|
5,827,759
|
|
8,380,661
|
John Schmid
|
|
8,615,211
|
|
5,831,931
|
|
8,380,661
|
For
|
|
Against
|
|
Abstain
|
22,622,466
|
|
191,447
|
|
13,890
|
Date: May 8, 2019
|
|
Xeris Pharmaceuticals, Inc.
|
||
|
|
|
|
|
|
|
By:
|
/s/ Barry M. Deutsch
|
|
|
|
|
|
Name: Barry M. Deutsch
|
|
|
|
|
Title:
Chief Financial Officer
|